Annual Cash & Cash Equivalents
$13.76 M
+$6.12 M+80.20%
December 31, 2023
Summary
- As of February 7, 2025, MIST annual cash & cash equivalents is $13.76 million, with the most recent change of +$6.12 million (+80.20%) on December 31, 2023.
- During the last 3 years, MIST annual cash & cash equivalents has fallen by -$58.55 million (-80.97%).
- MIST annual cash & cash equivalents is now -88.52% below its all-time high of $119.82 million, reached on December 31, 2019.
Performance
MIST Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$12.80 M
-$463.00 K-3.49%
September 30, 2024
Summary
- As of February 7, 2025, MIST quarterly cash and cash equivalents is $12.80 million, with the most recent change of -$463.00 thousand (-3.49%) on September 30, 2024.
- Over the past year, MIST quarterly cash and cash equivalents has increased by +$2.92 million (+29.56%).
- MIST quarterly cash and cash equivalents is now -89.32% below its all-time high of $119.82 million, reached on December 31, 2019.
Performance
MIST Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MIST Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +80.2% | +29.6% |
| 3 y3 years | -81.0% | -82.7% |
| 5 y5 years | -84.0% | -82.7% |
MIST Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -87.9% | +80.2% | -88.8% | +67.6% |
| 5 y | 5-year | -88.5% | +80.2% | -89.3% | +67.6% |
| alltime | all time | -88.5% | +80.2% | -89.3% | +67.6% |
Milestone Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $12.80 M(-3.5%) |
| Jun 2024 | - | $13.26 M(+30.9%) |
| Mar 2024 | - | $10.13 M(-26.4%) |
| Dec 2023 | $13.76 M(+80.2%) | $13.76 M(+39.3%) |
| Sep 2023 | - | $9.88 M(-69.7%) |
| Jun 2023 | - | $32.59 M(-55.9%) |
| Mar 2023 | - | $73.95 M(+868.5%) |
| Dec 2022 | $7.64 M(-93.3%) | $7.64 M(-79.5%) |
| Sep 2022 | - | $37.29 M(-41.0%) |
| Jun 2022 | - | $63.24 M(-31.4%) |
| Mar 2022 | - | $92.24 M(-19.2%) |
| Dec 2021 | $114.14 M | $114.14 M(+2.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $111.43 M(+13.9%) |
| Jun 2021 | - | $97.79 M(+36.1%) |
| Mar 2021 | - | $71.86 M(-0.6%) |
| Dec 2020 | $72.31 M(-39.7%) | $72.31 M(+54.1%) |
| Sep 2020 | - | $46.91 M(-12.2%) |
| Jun 2020 | - | $53.43 M(-47.5%) |
| Mar 2020 | - | $101.82 M(-15.0%) |
| Dec 2019 | $119.82 M(+39.4%) | $119.82 M(+12.5%) |
| Sep 2019 | - | $106.50 M(-3.9%) |
| Jun 2019 | - | $110.82 M(+55.6%) |
| Mar 2019 | - | $71.24 M(-17.1%) |
| Dec 2018 | $85.95 M(+690.0%) | $85.95 M |
| Dec 2017 | $10.88 M | - |
FAQ
- What is Milestone Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Milestone Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Milestone Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of MIST is $13.76 M
What is the all time high annual cash & cash equivalents for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high annual cash & cash equivalents is $119.82 M
What is Milestone Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, MIST annual cash & cash equivalents has changed by +$6.12 M (+80.20%)
What is Milestone Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MIST is $12.80 M
What is the all time high quarterly cash and cash equivalents for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high quarterly cash and cash equivalents is $119.82 M
What is Milestone Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, MIST quarterly cash and cash equivalents has changed by +$2.92 M (+29.56%)